Zebra Capital Management’s Usana Health Sciences USNA Stock Holding History

Zebra Capital Management’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,578	Closed	-$238K	–	175
2021 Q3	$238K	Buy	+2,578	New	+$248K	0.29%	128
2021 Q1	–	Sell	-3,380	Closed	-$261K	–	254
2020 Q4	$261K	Sell	3,380 -104	-3%	-$8.04K	0.33%	132
2020 Q3	$257K	Buy	+3,484	New	+$280K	0.4%	123
2018 Q2	–	Sell	-9,698	Closed	-$833K	–	361
2018 Q1	$833K	Sell	9,698 -5,433	-36%	-$421K	0.3%	164
2017 Q4	$1.12M	Buy	15,131 +2,876	+23%	+$192K	0.38%	112
2017 Q3	$707K	Sell	12,255 -728	-6%	-$43K	0.23%	189
2017 Q2	$832K	Sell	12,983 -690	-5%	-$42.5K	0.26%	178
2017 Q1	$788K	Buy	+13,673	New	+$816K	0.25%	178
2014 Q4	–	Sell	-15,448	Closed	-$569K	–	260
2014 Q3	$569K	Sell	15,448 -172	-1%	-$6.21K	0.23%	188
2014 Q2	$610K	Buy	+15,620	New	+$580K	0.23%	190

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Zebra Capital Management's USNA Position: Q4 2021 in Review

Zebra Capital Management sold out of Usana Health Sciences (USNA) in Q4 2021, closing a stake of 2,578 shares — an estimated $238K sold.

Zebra Capital Management first reported a position in USNA in Q2 2014 and held it in 10 quarters. The position peaked at $1.12M in Q4 2017. 191 funds tracked by Wall St. Rank hold USNA as of Q4 2021.

Zebra Capital Management reported no remaining Usana Health Sciences position as of Q4 2021 after selling out during the quarter.
Zebra Capital Management sold 2,578 Usana Health Sciences shares in Q4 2021, an estimated $238K.
Zebra Capital Management first reported a position in Usana Health Sciences in Q2 2014 and held it in 10 quarters.
Zebra Capital Management's Usana Health Sciences position peaked at $1.12M in Q4 2017.
191 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2021.

Based on Zebra Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.